Literature DB >> 3014867

Identification and application of additional restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.

J E Fox, A M Hack, W A Fenton, L E Rosenberg.   

Abstract

Two additional restriction fragment length polymorphisms (RFLPs) have been identified at the human ornithine transcarbamylase (OTC) locus. Approximately 11% of women are heterozygous for an RFLP characterized by polymorphic bands at 3.7 and 3.6 kilobasepairs (kbp) observed after DNA digestion with TaqI. Twenty-nine percent of women are heterozygous for an RFLP characterized by polymorphic bands at 18.0 and 5.2 kbp observed after digestion with BamHI. Thus, in combination with the previously reported RFLPs identified using MspI, the X chromosomes in approximately 80% of women at risk for having a son with OTC deficiency are distinguishable by RFLPs at the OTC locus. Furthermore, we show that these RFLPs will be useful in families for prenatal diagnosis of OTC deficiency, carrier detection, and carrier exclusion.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3014867      PMCID: PMC1684839     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Fetal liver biopsy for prenatal diagnosis of ornithine carbamyl transferase deficiency.

Authors:  C H Rodeck; A D Patrick; M E Pembrey; C Tzannatos; A E Whitfield
Journal:  Lancet       Date:  1982-08-07       Impact factor: 79.321

2.  Direct identification of sickle cell anemia by blot hybridization.

Authors:  R F Geever; L B Wilson; F S Nallaseth; P F Milner; M Bittner; J T Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

3.  Regional localization on the human X of DNA segments cloned from flow sorted chromosomes.

Authors:  L M Kunkel; U Tantravahi; M Eisenhard; S A Latt
Journal:  Nucleic Acids Res       Date:  1982-03-11       Impact factor: 16.971

4.  Molecular cloning of the cDNA coding for rat ornithine transcarbamoylase.

Authors:  A L Horwich; J P Kraus; K Williams; F Kalousek; W Konigsberg; L E Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

5.  Gene deletion and restriction fragment length polymorphisms at the human ornithine transcarbamylase locus.

Authors:  R Rozen; J Fox; W A Fenton; A L Horwich; L E Rosenberg
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

6.  Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.

Authors:  S W Brusilow; M Danney; L J Waber; M Batshaw; B Burton; L Levitsky; K Roth; C McKeethren; J Ward
Journal:  N Engl J Med       Date:  1984-06-21       Impact factor: 91.245

7.  Structure and expression of a complementary DNA for the nuclear coded precursor of human mitochondrial ornithine transcarbamylase.

Authors:  A L Horwich; W A Fenton; K R Williams; F Kalousek; J P Kraus; R F Doolittle; W Konigsberg; L E Rosenberg
Journal:  Science       Date:  1984-06-08       Impact factor: 47.728

8.  Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies.

Authors:  M Msall; M L Batshaw; R Suss; S W Brusilow; E D Mellits
Journal:  N Engl J Med       Date:  1984-06-07       Impact factor: 91.245

9.  Prenatal diagnosis of ornithine transcarbamylase deficiency utilizing fetal liver biopsy.

Authors:  W Holzgreve; M S Golbus
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

10.  Treatment of inborn errors of urea synthesis: activation of alternative pathways of waste nitrogen synthesis and excretion.

Authors:  M L Batshaw; S Brusilow; L Waber; W Blom; A M Brubakk; B K Burton; H M Cann; D Kerr; P Mamunes; R Matalon; D Myerberg; I A Schafer
Journal:  N Engl J Med       Date:  1982-06-10       Impact factor: 91.245

View more
  9 in total

1.  Identification of RNA splicing errors resulting in human ornithine transcarbamylase deficiency.

Authors:  R P Carstens; W A Fenton; L R Rosenberg
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene.

Authors:  D Hentzen; A Pelet; D Feldman; D Rabier; J Berthelot; A Munnich
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

3.  Family studies in ornithine transcarbamylase deficiency.

Authors:  L G Svirklys; B Wilcken; J Hammond; A G Mackinlay; W J O'Sullivan
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

4.  Improved molecular diagnostics for ornithine transcarbamylase deficiency.

Authors:  M Grompe; C T Caskey; R G Fenwick
Journal:  Am J Hum Genet       Date:  1991-02       Impact factor: 11.025

5.  Site specific screening for point mutations in ornithine transcarbamylase deficiency.

Authors:  D Feldmann; J M Rozet; A Pelet; D Hentzen; P Briand; P Hubert; C Largilliere; D Rabier; J P Farriaux; A Munnich
Journal:  J Med Genet       Date:  1992-07       Impact factor: 6.318

6.  Carrier detection in a partially dominant X-linked disease: ornithine transcarbamylase deficiency.

Authors:  A Pelet; A Rotig; C Bonaïti-Pellié; D Rabier; V Cormier; E Toumas; D Hentzen; J M Saudubray; A Munnich
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

Review 7.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

8.  Four novel gene mutations in five Japanese male patients with neonatal or late onset OTC deficiency: application of PCR-single-strand conformation polymorphisms for all exons and adjacent introns [corrected].

Authors:  T Matsuura; R Hoshide; C Setoyama; K Shimada; Y Hase; T Yanagawa; M Kajita; I Matsuda
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

9.  Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency.

Authors:  A Maddalena; J E Spence; W E O'Brien; R L Nussbaum
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.